Pink Sheet Podcast: Medicare Inflation Rebates And Negotiation, Leqembi Reimbursement, US FDA Gene Therapy Chief
Pink Sheet reporter and editors discuss the first round of mandated Medicare inflation rebates and new guidance on price negotiations, consider the VA’s decision to cover the Alzheimer’s drug Leqembi, and the US FDA continuing to search for a cell and gene therapy office leader.
You may also be interested in...
Game On: Medicare Will Parry Manufacturer Efforts To Sidestep Price Negotiation, Guidance Says
CMS will need to continue to be ‘savvy’ to strategies brand manufacturers already employ to shape the landscape for generic and biosimilar competition, policy expert says.
US FDA Expands In-Person Meeting Eligibility, But So Far No Takers
The agency has not scheduled a hybrid meeting (with some staff meeting in person and others joining via videoconference) since allowing the format in mid-February.
Neonatal Drug Development Could Benefit From Rare Disease Experience
Early parent involvement in drug development and clinical trial design could improve recruitment and outcomes, stakeholders argue.